NEW YORK (GenomeWeb News) – Sequenom today said that increased sales of its MassArray system and consumables drove a 25-percent increase in second-quarter revenues to $12.8 million from $10.2 million in the second quarter of 2007.
 
Harry Stylli, president and CEO of Sequenom, said in a conference call to discuss the company’s financial results that the firm placed around 16 MassArray systems during the quarter.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.